Eli Lilly and Company (LLY): Price and Financial Metrics
Eli Lilly and Company (LLY)
Today's Latest Price: $141.21 USD
0.35 (-0.25%)
Updated Jan 23 12:00am
Add LLY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
LLY Stock Summary
- LLY has a higher market value than 98.7% of US stocks; more precisely, its current market capitalization is $135,484,053,096.
- The capital turnover (annual revenue relative to shareholder's equity) for LLY is 6.69 -- better than 94.37% of US stocks.
- Over the past twelve months, LLY has reported earnings growth of 161.78%, putting it ahead of 92.79% of US stocks in our set.
- Stocks that are quantitatively similar to LLY, based on their financial statements, market capitalization, and price volatility, are AZN, AMGN, TXN, PYPL, and SNY.
- LLY's SEC filings can be seen here. And to visit ELI LILLY & Co's official web site, go to www.lilly.com.
LLY Daily Price Range
LLY 52-Week Price Range
LLY Stock Price Chart More Charts
LLY Price/Volume Stats
| Current price | $141.21 | 52-week high | $142.25 |
| Prev. close | $141.56 | 52-week low | $101.36 |
| Day low | $139.88 | Volume | 3,138,600 |
| Day high | $141.74 | Avg. volume | 3,715,353 |
| 50-day MA | $125.90 | Dividend yield | 1.83% |
| 200-day MA | $116.30 | Market Cap | 135.58B |
Eli Lilly and Company (LLY) Company Bio
Eli Lilly discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. The company was founded in 1876 and is based in Indianapolis, Indiana.
Top Stories View All
The Economy Keeps Weakening: 2 Critical Things Investors Need to Know
CRM 2 Tech Stocks To Consider Buying On Dips
Will Shares of Innovative Industrial Properties (IIPR) Continue Rising in 2020?
Best & Worst Performing Stock Industries for January 23, 2020
Best & Worst Performing Small Cap Stocks for January 23, 2020
View All Top Stories
Loading social stream, please wait...